Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 CT Optional)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 20 May 2026
- Closes
- 21 Aug 2028, 23:59 UTC
- Value
- USD 2,000,000
- Reference
- RFA-DC-27-003
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 CT Optional)”. Submissions close on 21 August 2028, 647 days from today. The stated value is USD 2,000,000. Quote reference RFA-DC-27-003 in any correspondence with the buyer. FreeTender has recorded 459 notices from this buyer since 2023, 368 of them currently open. There are 385 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on Grants.gov (US federal)
Applicants need a UEI from SAM.gov and a Grants.gov account registered to their organisation; allow several weeks for registration.
Details
The National Institute on Deafness and Other Communication Disorders (NIDCD), with the National Institute of Biomedical Imaging and Bioengineering (NIBIB) aims to support the development and/or adaptation of transformative in vivo high-resolution/high specificity imaging of the human olfactory system. Currently, there are limited non-invasive/minimally invasive technologies available for imaging the living human peripheral and central olfactory system with high spatial and temporal resolution. Imaging the olfactory system in the laboratory and in the clinic is essential to understanding underlying biological mechanisms as well as the etiology of an olfactory disorder. Such imaging has proven challenging due to the olfactory system"s unique anatomical and functional characteristics such as restricted accessibility, multiple cell types, and low signal resolution. Addressing these challenges requires multimodal approaches including leveraging existing advanced tools and technologies and developing new tools tailored for the olfactory system. Recent advances in minimally invasive and non-invasive imaging technologies, such as cell specific biomarkers, fluorescence imaging, specialized endoscopes, optical and acoustic imaging, molecular imaging, and hemodynamic and diffusion imaging have the potential to transform our ability to image and investigate the peripheral and central olfactory system in the living human with superior temporal and spatial resolution and eventually improve diagnostic accuracy of olfactory disorders. Applications must leverage advanced non-invasive/minimally invasive imaging technologies to visualize peripheral (e.g., olfactory- and non-olfactory epithelium) and central olfactory (e.g., olfactory bulb) targets at a level previously unattainable. In addition, projects should engage multidisciplinary teams combining expertise in olfaction, biomedical imaging, biochemistry, bioengineering, and biophysics, as appropriate. Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Estimated total programme funding: USD 2000000
Expected number of awards: 3
CFDA number(s): 93.173
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 459 notices from National Institutes of Health, going back to May 2023 — 368 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 385 open Healthcare & Pharma tenders in United States. This one closes in 647 days.
More from this buyer
- Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)· closes 10 Jun
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)· closes 16 Nov
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)· closes 5 Mar
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)· closes 10 Oct
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)· closes 17 Feb
Similar Healthcare & Pharma tenders
- Research Grants Supporting Scientific Discovery, Academic Research and New Studies· closes 18 Jan
- Tele-Emergency (Tele-Ed) High-Acuity Emergency Support and Telemedicine Sexual Assault Medical Forensic Evaluation support services for Great Plains Area Indian Health Service Units· closes 8 Dec
- NWI Offsite Pathology Services· closes 30 Nov
- Litter, Folding, Pole — 67 each, NSN 6530016631222· closes 18 Nov
- Jacobs Creek JCC Medical Services — General Health Care Services· closes 17 Nov
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Поставка медицинских масокГУЗ "СГКБ № 6 имени академика В.Н.Кошелева" · Russia
- Поставка медицинского оборудования (Термометр бесконтактный, весы медицинские напольные, пульсоксиметр на палец)ГОСУДАРСТВЕННОЕ АВТОНОМНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ "ЭНГЕЛЬССКАЯ ГОРОДСКАЯ КЛИНИЧЕСКАЯ БОЛЬНИЦА № 1" · Russia
- Поставка медицинских изделий (шприцы)ГБУЗ "ВОККВД" · Russia
- Оказание платных медицинских услуг (патологоанатомические исследования на 2027 год)ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ "ГОРОДСКАЯ КЛИНИЧЕСКАЯ БОЛЬНИЦА № 3" · Russia
- Поставка косметических средств (защитные патчи Эпилайк)ГБУЗ "ВОККВД" · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →